ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 2 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $418,000 | +56.0% | 4,500 | 0.0% | 0.01% | +50.0% |
| Q3 2021 | $268,000 | -12.7% | 4,500 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $307,000 | -1.6% | 4,500 | 0.0% | 0.01% | -14.3% |
| Q1 2021 | $312,000 | -9.8% | 4,500 | 0.0% | 0.01% | -41.7% |
| Q4 2020 | $346,000 | +2.7% | 4,500 | 0.0% | 0.01% | -14.3% |
| Q3 2020 | $337,000 | +19.1% | 4,500 | 0.0% | 0.01% | +40.0% |
| Q2 2020 | $283,000 | +38.7% | 4,500 | 0.0% | 0.01% | +66.7% |
| Q4 2019 | $204,000 | -1.0% | 4,500 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $206,000 | -22.0% | 4,500 | 0.0% | 0.01% | -14.3% |
| Q2 2019 | $264,000 | +30.7% | 4,500 | 0.0% | 0.01% | +16.7% |
| Q1 2019 | $202,000 | – | 4,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 4,190,000 | $321,918,000 | 5.54% |
| Prosight Management, LP | 145,700 | $11,194,000 | 5.17% |
| Integral Health Asset Management, LLC | 200,000 | $15,366,000 | 4.57% |
| Copernicus Capital Management, LLC | 3,740 | $287,000 | 4.47% |
| GREAT POINT PARTNERS LLC | 345,120 | $26,516,000 | 4.31% |
| Asymmetry Capital Management, L.P. | 101,245 | $7,779,000 | 3.55% |
| First Light Asset Management, LLC | 321,967 | $24,737,000 | 1.83% |
| DAFNA Capital Management LLC | 76,815 | $5,902,000 | 1.76% |
| SECTORAL ASSET MANAGEMENT INC | 320,059 | $24,590,000 | 1.73% |
| Nicholas Investment Partners, LP | 276,633 | $21,254,000 | 1.64% |